| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/11/2002 | US6403373 Isolated nucleic acid molecules associated with colon, renal, and stomach cancer and methods of using these |
| 06/11/2002 | US6403370 Generation an infection, reproduction, genetic engineering |
| 06/11/2002 | US6403361 Enzymatic method for modification of recombinant polypeptides |
| 06/11/2002 | US6403349 Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics |
| 06/11/2002 | US6403336 Dna segment encodes protective peptide-fused atriopeptin; microorganisms transformed with vectors; genetic engineering |
| 06/11/2002 | US6403335 Amino acid sequence; promotes survival of mesencephalic cells; nervous system and degenerative disorders; parkinson*s disease; genetic engineering |
| 06/11/2002 | US6403334 gidB from Staphylococcus aureus |
| 06/11/2002 | US6403325 Methods and compounds for treating alzheimer's disease |
| 06/11/2002 | US6403319 Mixing nucleic acid samples with hairpin primers; incubation, amplification, hybridization, and detection; sequence determination, genetic engineering |
| 06/11/2002 | US6403310 Human inositol monophosphatase H1 |
| 06/11/2002 | US6403307 Amplification of genomic dna or mrna or complement; analyzing for mutation |
| 06/11/2002 | US6403306 Detection and diagnosis of meningococcal strains; vaccines with capsular polysaccharide conjugates; genetic engineering |
| 06/11/2002 | US6403299 Transforming non-leflunomide resistant cell with dna sequence encoding deah box protein that binds atp and nucleic acid; culturing; modulating helicase activity; genetic engineering |
| 06/11/2002 | US6403122 Bioavailability based on a lipolytic indifferent vehicle, an absorption promoter and active n-methylated cyclic undecapeptides or macrolide lactones; self assembly drug delivery system (sadds); cyclosporins |
| 06/11/2002 | US6403112 Ectoin and ectoin derivatives as moisturizers in cosmetics |
| 06/11/2002 | US6403102 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/11/2002 | US6403101 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/11/2002 | US6403099 Conjugates formed from heat shock proteins and oligo-or polysaccharides |
| 06/11/2002 | US6403097 Deletion in the glycoprotein ge-gene |
| 06/11/2002 | US6403096 Dimer, linked by a disulfide bridge; improves the uptake of therapeutic and diagnostic agents at a tumor site |
| 06/11/2002 | US6403095 Treatment of primary and metastatic neoplastic diseases with HSP70-peptide complexes |
| 06/11/2002 | US6403094 Clostridium perfringens vaccines |
| 06/11/2002 | US6403092 Immune response modulator alpha-2 macroglobulin complex |
| 06/11/2002 | US6403091 Produced by the hybridoma having atcc accession no. hb 10916. |
| 06/11/2002 | US6403089 Inhibitors of fgl2; bacterial and viral infections, allograft and xenograft rejection, glomerulonephritis, cancer, gastrointestinal diseases and fetal loss; monoclonal and polyclonal antibodies which bind to fgl2 and prevent fibrin |
| 06/11/2002 | US6403088 Antibodies reactive with VEGF-C, a ligand for the Flt4 receptor tyrosine kinase (VEGFR-3) |
| 06/11/2002 | US6403087 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological disease |
| 06/11/2002 | US6403086 Administering extracts of morinda citrifolia, red wine, prune, blueberry, pomegranate, apple and an enzyme mixture |
| 06/11/2002 | US6403082 Administering polynucleotide |
| 06/11/2002 | US6403080 Methods of modulating an immune response to antigen, and cells for use in the method |
| 06/11/2002 | US6403079 Using polypeptide |
| 06/11/2002 | US6403078 Method and compositions for treating preterm labor and premature rupture of fetal membranes |
| 06/11/2002 | US6403077 Treatment regimes featuring an IL-10-containing chimeric polypeptide |
| 06/11/2002 | US6403076 Polypeptides |
| 06/11/2002 | US6403057 Microcapsules, method of making and their use |
| 06/11/2002 | US6402913 Separation of plasma components |
| 06/11/2002 | US6402733 Intrapulmonary delivery of polypeptide growth factors and cytokines |
| 06/11/2002 | CA2329858A1 Expression cloning of protein targets for phospholipids |
| 06/11/2002 | CA2276614C Analogs of parathyroid hormone |
| 06/11/2002 | CA2194375C Chondroitin lyase enzymes |
| 06/11/2002 | CA2169629C Human erythropoietin receptor fragment and antibodies thereto |
| 06/11/2002 | CA2152266C Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/turyosinase peptide antigens |
| 06/11/2002 | CA2124218C Cytotoxic drug therapy |
| 06/11/2002 | CA2103666C Products containing verapamil and trandolapril |
| 06/11/2002 | CA2088478C Cloning and expression of a rhoptry associated protein of p. falciparum |
| 06/11/2002 | CA2082390C Dna encoding human 5-ht1d receptors and uses thereof |
| 06/11/2002 | CA2048638C Fibroblast growth factor (fgf)-based stabilized compositions and the use thereof |
| 06/11/2002 | CA1341366C Molecular clones of the genome of htlv-iii |
| 06/06/2002 | WO2002045431A2 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | WO2002044736A2 Diagnosis and treatment of epidermal or skin diseases |
| 06/06/2002 | WO2002044718A2 S.aureus protein staau r2, gene encoding it and uses thereof |
| 06/06/2002 | WO2002044424A1 Compositions, methods, apparatus and products comprising a stathmin/oncoprotein 18 sequence for detecting and treating cancer |
| 06/06/2002 | WO2002044417A2 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044406A2 Projection against mycobacterial infections |
| 06/06/2002 | WO2002044396A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | WO2002044395A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 06/06/2002 | WO2002044394A2 Targetet retoviral vectors for cancer immunotherapy |
| 06/06/2002 | WO2002044393A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 06/06/2002 | WO2002044384A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 06/06/2002 | WO2002044382A1 Cytokine-like proteins |
| 06/06/2002 | WO2002044381A2 Human vno receptor (r1) |
| 06/06/2002 | WO2002044380A2 Master bone formation transcription factor: compositions and methods of use |
| 06/06/2002 | WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | WO2002044378A2 Wnt signalling assay, methods and uses thereof |
| 06/06/2002 | WO2002044374A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/06/2002 | WO2002044368A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 06/06/2002 | WO2002044366A2 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | WO2002044364A2 Polypeptides involved in immune response |
| 06/06/2002 | WO2002044363A1 Methods for modulating apoptotic cell death |
| 06/06/2002 | WO2002044362A1 Method of screening remedy for diabetes |
| 06/06/2002 | WO2002044360A2 Modified arginine deiminase |
| 06/06/2002 | WO2002044359A1 Enzyme with proteolytic activity |
| 06/06/2002 | WO2002044358A2 Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3 |
| 06/06/2002 | WO2002044357A2 Methods of using 18903 to treat pain and pain-related disorders |
| 06/06/2002 | WO2002044356A2 25206, a novel human short-chain dehydrogenase/reductase family member and uses thereof |
| 06/06/2002 | WO2002044351A2 Regulation of human fatty acid coa ligase |
| 06/06/2002 | WO2002044345A1 Methods and products for manipulating hematopoietic stem cells |
| 06/06/2002 | WO2002044342A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 06/06/2002 | WO2002044340A2 Novel nucleic acids and polypeptides |
| 06/06/2002 | WO2002044328A2 Anti-angiogenic polypeptides |
| 06/06/2002 | WO2002044325A2 Antisense modulation of src-1 expression |
| 06/06/2002 | WO2002044324A2 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 06/06/2002 | WO2002044321A2 Rna interference mediating small rna molecules |
| 06/06/2002 | WO2002044320A2 Human elongase genes and uses thereof |
| 06/06/2002 | WO2002044214A1 Methods for the synthesis of a modified hemoglobin solution |
| 06/06/2002 | WO2002044213A1 New cytochrome p450 proteins and the corresponding dna sequences |
| 06/06/2002 | WO2002044211A2 Endozepine like protein, polynucleotide encoding them and methods of using the same |
| 06/06/2002 | WO2002044210A2 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | WO2002044208A1 Methods of screening for agonists and antagonists of the hneaa81 receptor |
| 06/06/2002 | WO2002044203A2 Production of recombinant bmp-2 |
| 06/06/2002 | WO2002044202A2 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof |
| 06/06/2002 | WO2002044199A2 Neurotoxins with enhanced target specificity |
| 06/06/2002 | WO2002044198A2 Haplotypes of the slc1a4 gene |
| 06/06/2002 | WO2002044113A2 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 06/06/2002 | WO2002043807A2 Combinations of an angiotensin receptor antagonist and an anti-hypertensive drug or a statin, for the treatment of sexual dysfunction |
| 06/06/2002 | WO2002043785A2 Intraocular implants for preventing transplant rejection in the eye |
| 06/06/2002 | WO2002043774A2 Compositions and therapeutical use of polynucleotides encoding tcrs |
| 06/06/2002 | WO2002043773A2 Tissue specific prodrugs |
| 06/06/2002 | WO2002043771A2 Conjugates of glycosylated/galactosylated peptide |
| 06/06/2002 | WO2002043767A1 Improved oral delivery of peptides using enzyme-cleavable membrane translocators |